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Background
The prevalence of asthma has steadily increased during
the last decade, probably as the result of changes in the
environment, including reduced microbial exposure dur-
ing infancy. Accordingly, experimental studies have shown
that deliberate infections with live pathogens prevent the
development of allergic airway diseases in mice. Bacterial
extracts are currently used in children suffering from
repeated upper respiratory tract infections. In this study,
we have investigated whether bacterial extracts, commer-
cially available as Broncho-Vaxom (BV), could prevent
allergic airway disease in mice.
Results
Oral treatment with BV suppressed airway inflammation
through IL-10-dependent and MyD88-dependent mechan-
isms and induced the conversion of FoxP3-negative T cells
into FoxP3-positive regulatory T cells. Furthermore, CD4-
positive T cells purified from the trachea of BV-treated
mice conferred protection against airway inflammation
when adoptively transferred into sensitized mice.
Conclusion
Treatment with BV could possibly be a safe and efficient
strategy to prevent the development of allergic disease in
children.
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